Residential Construction
Compare Stocks
5 / 10Stock Comparison
GRBK vs TMHC vs DHI vs LEN vs PHM
Revenue, margins, valuation, and 5-year total return — side by side.
Residential Construction
Residential Construction
Residential Construction
Residential Construction
GRBK vs TMHC vs DHI vs LEN vs PHM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Residential Construction | Residential Construction | Residential Construction | Residential Construction | Residential Construction |
| Market Cap | $2.83B | $5.56B | $42.29B | $18.93B | $22.46B |
| Revenue (TTM) | $2.10B | $7.61B | $33.35B | $34.13B | $16.83B |
| Net Income (TTM) | $313M | $672M | $3.17B | $2.08B | $2.04B |
| Gross Margin | 30.5% | 22.4% | 22.8% | 17.6% | 26.1% |
| Operating Margin | 19.5% | 13.2% | 11.8% | 7.7% | 16.4% |
| Forward P/E | 11.0x | 11.2x | 13.7x | 14.2x | 11.7x |
| Total Debt | $335M | $2.36B | $6.03B | $6.32B | $2.40B |
| Cash & Equiv. | $191M | $851M | $2.99B | $3.80B | $2.01B |
GRBK vs TMHC vs DHI vs LEN vs PHM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Green Brick Partner… (GRBK) | 100 | 613.8 | +513.8% |
| Taylor Morrison Hom… (TMHC) | 100 | 307.7 | +207.7% |
| D.R. Horton, Inc. (DHI) | 100 | 264.0 | +164.0% |
| Lennar Corporation (LEN) | 100 | 145.1 | +45.1% |
| PulteGroup, Inc. (PHM) | 100 | 344.1 | +244.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GRBK vs TMHC vs DHI vs LEN vs PHM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GRBK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth -0.0%, EPS growth -16.3%, 3Y rev CAGR 6.1%
- 7.4% 10Y total return vs PHM's 5.7%
- -0.0% revenue growth vs DHI's -6.9%
- 14.9% margin vs LEN's 6.1%
TMHC ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.34 vs LEN's 43.27
- Lower P/E (11.2x vs 11.7x), PEG 0.34 vs 0.71
DHI is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.85, Low D/E 24.4%, current ratio 17.39x
- Beta 0.85, yield 1.1%, current ratio 17.39x
- Beta 0.85 vs GRBK's 1.06
- +20.3% vs LEN's -16.8%
LEN is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.92, yield 2.3%
- 2.3% yield, 12-year raise streak, vs GRBK's 0.1%, (1 stock pays no dividend)
Among these 5 stocks, PHM doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.0% revenue growth vs DHI's -6.9% | |
| Value | Lower P/E (11.2x vs 11.7x), PEG 0.34 vs 0.71 | |
| Quality / Margins | 14.9% margin vs LEN's 6.1% | |
| Stability / Safety | Beta 0.85 vs GRBK's 1.06 | |
| Dividends | 2.3% yield, 12-year raise streak, vs GRBK's 0.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +20.3% vs LEN's -16.8% | |
| Efficiency (ROA) | 13.0% ROA vs LEN's 6.0%, ROIC 15.4% vs 7.9% |
GRBK vs TMHC vs DHI vs LEN vs PHM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GRBK vs TMHC vs DHI vs LEN vs PHM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GRBK leads in 2 of 6 categories
TMHC leads 1 • LEN leads 1 • DHI leads 0 • PHM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GRBK and DHI each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LEN is the larger business by revenue, generating $34.1B annually — 16.3x GRBK's $2.1B. GRBK is the more profitable business, keeping 14.9% of every revenue dollar as net income compared to LEN's 6.1%. On growth, DHI holds the edge at -2.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.1B | $7.6B | $33.3B | $34.1B | $16.8B |
| EBITDAEarnings before interest/tax | $415M | $1.0B | $4.0B | $2.8B | $2.8B |
| Net IncomeAfter-tax profit | $313M | $672M | $3.2B | $2.1B | $2.0B |
| Free Cash FlowCash after capex | $208M | $710M | $3.5B | $28M | $1.6B |
| Gross MarginGross profit ÷ Revenue | +30.5% | +22.4% | +22.8% | +17.6% | +26.1% |
| Operating MarginEBIT ÷ Revenue | +19.5% | +13.2% | +11.8% | +7.7% | +16.4% |
| Net MarginNet income ÷ Revenue | +14.9% | +8.8% | +9.5% | +6.1% | +12.1% |
| FCF MarginFCF ÷ Revenue | +9.9% | +9.3% | +10.5% | +0.1% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.6% | -26.8% | -2.3% | -6.5% | -12.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -22.9% | -51.2% | -13.2% | -52.5% | -30.4% |
Valuation Metrics
TMHC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 7.7x trailing earnings, TMHC trades at a 39% valuation discount to DHI's 12.6x P/E. Adjusting for growth (PEG ratio), TMHC offers better value at 0.23x vs LEN's 43.27x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.8B | $5.6B | $42.3B | $18.9B | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $7.1B | $45.3B | $21.4B | $22.9B |
| Trailing P/EPrice ÷ TTM EPS | 9.29x | 7.65x | 12.62x | 10.99x | 10.51x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.98x | 11.22x | 13.71x | 14.24x | 11.68x |
| PEG RatioP/E ÷ EPS growth rate | 0.36x | 0.23x | 1.01x | 43.27x | 0.64x |
| EV / EBITDAEnterprise value multiple | 7.19x | 6.18x | 10.02x | 7.43x | 7.35x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 0.68x | 1.23x | 0.55x | 1.30x |
| Price / BookPrice ÷ Book value/share | 1.49x | 0.95x | 1.83x | 1.02x | 1.80x |
| Price / FCFMarket cap ÷ FCF | 13.60x | 6.88x | 12.88x | 671.74x | 12.84x |
Profitability & Efficiency
GRBK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GRBK delivers a 17.0% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $9 for LEN. GRBK carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMHC's 0.37x. On the Piotroski fundamental quality scale (0–9), PHM scores 5/9 vs LEN's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.0% | +10.8% | +12.9% | +9.2% | +15.9% |
| ROA (TTM)Return on assets | +13.0% | +6.9% | +8.9% | +6.0% | +11.4% |
| ROICReturn on invested capital | +15.4% | +11.0% | +12.1% | +7.9% | +17.2% |
| ROCEReturn on capital employed | +19.1% | +13.2% | +13.1% | +8.8% | +20.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 4 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.17x | 0.37x | 0.24x | 0.29x | 0.19x |
| Net DebtTotal debt minus cash | $144M | $1.5B | $3.0B | $2.5B | $394M |
| Cash & Equiv.Liquid assets | $191M | $851M | $3.0B | $3.8B | $2.0B |
| Total DebtShort + long-term debt | $335M | $2.4B | $6.0B | $6.3B | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 19.94x | 44.09x | 198.24x | 5590.17x |
Total Returns (Dividends Reinvested)
GRBK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GRBK five years ago would be worth $25,408 today (with dividends reinvested), compared to $8,891 for LEN. Over the past 12 months, DHI leads with a +20.3% total return vs LEN's -16.8%. The 3-year compound annual growth rate (CAGR) favors PHM at 20.8% vs LEN's -6.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.9% | +1.1% | +0.8% | -14.9% | -1.6% |
| 1-Year ReturnPast 12 months | +10.5% | +2.0% | +20.3% | -16.8% | +16.3% |
| 3-Year ReturnCumulative with dividends | +31.2% | +37.4% | +38.6% | -18.6% | +76.2% |
| 5-Year ReturnCumulative with dividends | +154.1% | +85.7% | +46.7% | -11.1% | +95.4% |
| 10-Year ReturnCumulative with dividends | +742.1% | +321.2% | +424.3% | +122.6% | +571.2% |
| CAGR (3Y)Annualised 3-year return | +9.5% | +11.2% | +11.5% | -6.6% | +20.8% |
Risk & Volatility
Evenly matched — TMHC and DHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
DHI is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than GRBK's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TMHC currently trades 82.0% from its 52-week high vs LEN's 60.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 0.92x | 0.85x | 0.92x | 1.01x |
| 52-Week HighHighest price in past year | $80.97 | $72.50 | $184.55 | $144.24 | $144.27 |
| 52-Week LowLowest price in past year | $56.85 | $54.58 | $114.17 | $83.03 | $95.20 |
| % of 52W HighCurrent price vs 52-week peak | +81.1% | +82.0% | +79.1% | +60.8% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 47.0 | 49.0 | 49.6 | 48.5 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 200K | 1.1M | 2.6M | 2.9M | 1.7M |
Analyst Outlook
LEN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GRBK as "Hold", TMHC as "Buy", DHI as "Hold", LEN as "Buy", PHM as "Hold". Consensus price targets imply 24.0% upside for TMHC (target: $74) vs 12.3% for DHI (target: $164). For income investors, LEN offers the higher dividend yield at 2.30% vs PHM's 0.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $73.75 | $163.86 | $102.14 | $141.22 |
| # AnalystsCovering analysts | 11 | 30 | 52 | 50 | 44 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | — | +1.1% | +2.3% | +0.8% |
| Dividend StreakConsecutive years of raises | 3 | 1 | 11 | 12 | 7 |
| Dividend / ShareAnnual DPS | $0.07 | — | $1.60 | $2.02 | $0.89 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | +6.9% | +10.1% | +9.6% | +5.5% |
GRBK leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). TMHC leads in 1 (Valuation Metrics). 2 tied.
GRBK vs TMHC vs DHI vs LEN vs PHM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GRBK or TMHC or DHI or LEN or PHM a better buy right now?
For growth investors, Green Brick Partners, Inc.
(GRBK) is the stronger pick with -0. 0% revenue growth year-over-year, versus -6. 9% for D. R. Horton, Inc. (DHI). Taylor Morrison Home Corporation (TMHC) offers the better valuation at 7. 7x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate Taylor Morrison Home Corporation (TMHC) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GRBK or TMHC or DHI or LEN or PHM?
On trailing P/E, Taylor Morrison Home Corporation (TMHC) is the cheapest at 7.
7x versus D. R. Horton, Inc. at 12. 6x. On forward P/E, Green Brick Partners, Inc. is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Taylor Morrison Home Corporation wins at 0. 34x versus Lennar Corporation's 43. 27x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GRBK or TMHC or DHI or LEN or PHM?
Over the past 5 years, Green Brick Partners, Inc.
(GRBK) delivered a total return of +154. 1%, compared to -11. 1% for Lennar Corporation (LEN). Over 10 years, the gap is even starker: GRBK returned +742. 1% versus LEN's +122. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GRBK or TMHC or DHI or LEN or PHM?
By beta (market sensitivity over 5 years), D.
R. Horton, Inc. (DHI) is the lower-risk stock at 0. 85β versus Green Brick Partners, Inc. 's 1. 06β — meaning GRBK is approximately 25% more volatile than DHI relative to the S&P 500. On balance sheet safety, Green Brick Partners, Inc. (GRBK) carries a lower debt/equity ratio of 17% versus 37% for Taylor Morrison Home Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — GRBK or TMHC or DHI or LEN or PHM?
By revenue growth (latest reported year), Green Brick Partners, Inc.
(GRBK) is pulling ahead at -0. 0% versus -6. 9% for D. R. Horton, Inc. (DHI). On earnings-per-share growth, the picture is similar: Taylor Morrison Home Corporation grew EPS -6. 0% year-over-year, compared to -44. 2% for Lennar Corporation. Over a 3-year CAGR, GRBK leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GRBK or TMHC or DHI or LEN or PHM?
Green Brick Partners, Inc.
(GRBK) is the more profitable company, earning 14. 9% net margin versus 6. 0% for Lennar Corporation — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GRBK leads at 19. 5% versus 8. 0% for LEN. At the gross margin level — before operating expenses — GRBK leads at 30. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GRBK or TMHC or DHI or LEN or PHM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Taylor Morrison Home Corporation (TMHC) is the more undervalued stock at a PEG of 0. 34x versus Lennar Corporation's 43. 27x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Green Brick Partners, Inc. (GRBK) trades at 11. 0x forward P/E versus 14. 2x for Lennar Corporation — 3. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TMHC: 24. 0% to $73. 75.
08Which pays a better dividend — GRBK or TMHC or DHI or LEN or PHM?
In this comparison, LEN (2.
3% yield), DHI (1. 1% yield), PHM (0. 8% yield) pay a dividend. GRBK, TMHC do not pay a meaningful dividend and should not be held primarily for income.
09Is GRBK or TMHC or DHI or LEN or PHM better for a retirement portfolio?
For long-horizon retirement investors, D.
R. Horton, Inc. (DHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85), 1. 1% yield, +424. 3% 10Y return). Both have compounded well over 10 years (DHI: +424. 3%, TMHC: +321. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GRBK and TMHC and DHI and LEN and PHM?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
DHI, LEN, PHM pay a dividend while GRBK, TMHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.